Literature DB >> 2504595

Elimination of vancomycin during hemofiltration.

P Rawer1, K E Seim.   

Abstract

The study was designed to establish guidelines for vancomycin treatment of patients with acute renal failure undergoing hemofiltration. During 27 hemofiltration treatments in four anuric patients requiring daily consecutive hemofiltration therapy, plasma levels and elimination rates of vancomycin were measured. Regression analysis of the initial vancomycin concentration versus the total amount of vancomycin eliminated showed a clear linear relationship (r = 0.91), thus permitting prediction of the total elimination via hemofiltration by measurement of the initial plasma concentration. Applying these calculations the dosage in patients undergoing hemofiltration can be determined by monitoring the initial plasma concentration. The findings also indicate that hemofiltration is an effective method for treatment of vancomycin intoxication.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504595     DOI: 10.1007/bf01967474

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

Review 1.  Continuous arteriovenous hemofiltration in acute renal failure.

Authors:  T A Golper
Journal:  Am J Kidney Dis       Date:  1985-12       Impact factor: 8.860

2.  Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

Authors:  R C Moellering; D J Krogstad; D J Greenblatt
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

3.  Disposition of vancomycin during hemofiltration.

Authors:  G R Matzke; M B O'Connell; A J Collins; P R Keshaviah
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875

4.  Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.

Authors:  B F Farber; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

  4 in total
  1 in total

1.  Pharmacokinetics of vancomycin during continuous hemodiafiltration.

Authors:  C Santré; O Leroy; M Simon; H Georges; B Guery; C Beuscart; G Beaucaire
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.